MRC Epidemiology Unit
A new study published today in Nature Medicine has identified key risk factors that increase the likelihood of individuals developing not only one but multiple non-communicable diseases, which include cardiovascular disease, […]
Discovery of genetic regulators of human metabolism and health
An international team led by researchers at the MRC Epidemiology Unit has used a cross-platform approach across several large human studies to identify hundreds of novel genetic variants that regulate […]
Consortium led by Unit researchers develops open platform to help discover COVID-19 drugs
An international consortium led by MRC researchers has developed an open access platform to help prioritise drug discovery and repurposing efforts for the current COVID-19 pandemic. The platform provides information on […]
Unit scientists join call for urgent action to address global diabetes epidemic
Researchers from the MRC Epidemiology Unit are part of the international team behind a new report in The Lancet summarising the best evidence for effectively managing and preventing diabetes. This […]
Open-access reference genetic dataset for the world’s largest study of incident type 2 diabetes
Type 2 diabetes is a chronic metabolic disease characterised by elevated levels of glucose in the blood, and presents a major and growing global public health challenge. While both genes […]
Researchers uncover genetic marker associated with fatty liver disease
The link between a specific genetic marker and severity of non-alcoholic fatty liver disease (NAFLD) has been validated in this study by researchers from several institutions and organisations, including the […]
MRC Epidemiology Unit launches study to monitor COVID-19 in 12,000 Cambridgeshire residents
Participants in Cambridgeshire’s Fenland Study are being invited to join an innovative study that will use a home-administered blood sampling device to find out how many have evidence in their […]
Study highlights potential for ‘liquid health check’ to predict disease risk
Proteins in our blood could in future help provide a comprehensive ‘liquid health check’, assessing our health and predicting the likelihood that we will we will develop a range of […]
Discovery of genetic variants that protect against obesity and type 2 diabetes could lead to new weight loss medicines
Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, suggests new research from the University of Cambridge. The […]
Circulating glycine is genetically associated with lower risk of coronary heart disease
A new cross-platform meta-analysis of genome-wide association studies for glycine in more than 80,000 participants, led by Dr Claudia Langenberg and PhD student Laura Wittemans of our Aetiology of Diabetes Programme, and published […]